Harnessing microbiome-based biomarkers: a multidisciplinary Delphi Consensus and EU’s new initiative
Delphi survey highlights promises and challenges in clinical use of microbiome-based biomarkers.
‘We are trying to understand how Lactobacillus reuteri DSM 17938 is able to cross-feed and cross-talk to other bacteria’ - Gianfranco Grompone, scientific director at BioGaia.
The findings may help to identify new biomarkers for food addiction and assess whether beneficial bacteria could serve as potential new treatments for compulsive eating.
Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study announce partnership to better understand the molecular mechanisms of rheumatoid arthritis.
Microbiomepost conducted an exclusive interview with Charlotte Neumann, researcher at Medical University of Graz, about the role of Archaea and obligate anaerobes in the development of the infant oral microbiome.
The findings indicate that MAIT cells act as detectors of gut inflammation by interacting with the microbiota.
The balance of specific microbes in the gut can help predict who will respond to immunotherapy drugs.
Franco Vicariotto, Ospedale S. Pio X, Milan, talks about the results from a clinical trial in post-menopausal women.
Arpana Church (UCLA): ‘We’re hoping to better understand the role of dietary polyphenols in slowing the development of cognitive decline and how this is all influenced by the gut microbiome’.
Microbiomepost conducted an exclusive interview with Martina Piacente, from Ebris - European Biomedical Research Institute of Salerno, about the role of gut microbiome in Autism Spectrum Disorder.
